Life Science Company News

Reset
Results 281 - 300 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »

Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Chimerix, Inc.

PolyPid to Report First Quarter 2024 Financial Results and Operational Highlights on May 8, 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  PolyPid Ltd.

atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  atai Life Sciences N.V.

HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Hookipa Pharma Inc.

Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Travere Therapeutics, Inc.

InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  InflaRx N.V.

Avenue Therapeutics Announces Reverse Stock Split

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Avenue Therapeutics, Inc.

Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Algernon Pharmaceuticals Inc.

Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Immutep Limited

IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  IN8bio Inc.

scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  scPharmaceuticals Inc.

SensaSure Technologies and Verde Bio Holdings Provide Update on Pending Merger

Read more ››
By: GlobeNewswire - 24 Apr 2024

BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Brainsway Ltd.

Oruka Therapeutics Expands Leadership Team, Naming Joana Goncalves, MBChB, as Chief Medical Officer

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Oruka Therapeutics, Inc.

LifeMD to Report First Quarter 2024 Financial Results on May 8

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  LifeMD, Inc

Tonix Pharmaceuticals Announces Presentation at Planet MicroCap Showcase

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Tonix Pharmaceuticals Holding Corp.

Scilex Holding Company Announces $15 Million Registered Direct Offering

Read more ››
By: GlobeNewswire - 24 Apr 2024

BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  BioStem Technologies, Inc.

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Vericel Corporation

United Kingdom’s MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism

Read more ››
By: GlobeNewswire - 24 Apr 2024
Related companies:  Ascendis Pharma A/S
Results 281 - 300 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »